Cargando…

Molecular predictors of post-transplant survival in acute myeloid leukemia

Detalles Bibliográficos
Autores principales:	Qin, Tong, Wu, Sun, Zhao, Hongmian, Xu, Keman, Fu, Huaping, Cheng, Zhiheng, Pang, Yifan, Han, Yu, Chen, Li, Wang, Chao, Zhang, Yijie, Ke, Xiaoyan, Xu, Kailin, Shi, Jinlong, Fu, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802651/ https://www.ncbi.nlm.nih.gov/pubmed/29233964 http://dx.doi.org/10.1038/s41408-017-0027-6

Ejemplares similares

High expression of CPNE3 predicts adverse prognosis in acute myeloid leukemia
por: Fu, Lin, et al.
Publicado: (2017)

High expression of ETS2 predicts poor prognosis in acute myeloid leukemia and may guide treatment decisions
por: Fu, Lin, et al.
Publicado: (2017)

High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemia
por: Fu, Lin, et al.
Publicado: (2016)

High expression of RUNX1 is associated with poorer outcomes in cytogenetically normal acute myeloid leukemia
por: Fu, Lin, et al.
Publicado: (2016)

High expression of DOCK2 indicates good prognosis in acute myeloid leukemia
por: Hu, Ning, et al.
Publicado: (2019)

High expression of MiR-98 is a good prognostic factor in acute myeloid leukemia patients treated with chemotherapy alone
por: Hu, Ning, et al.
Publicado: (2019)

High expression of AK1 predicts inferior prognosis in acute myeloid leukemia patients undergoing chemotherapy
por: Qin, Tong, et al.
Publicado: (2020)

Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia
por: Liu, Yan, et al.
Publicado: (2019)

Impact of emerging ACA on survival in chronic myeloid leukemia (CML)
por: Hehlmann, Rüdiger, et al.
Publicado: (2022)

DLC1 deficiency at diagnosis predicts poor prognosis in acute myeloid leukemia
por: Li, Xueqian, et al.
Publicado: (2022)

Acute Myeloid Leukemia Masquerading as Acute Appendicitis
por: Shen, Kai, et al.
Publicado: (2017)

Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant
por: Pabon, Cindy M., et al.
Publicado: (2021)

The clinical impact of IKZF1 mutation in acute myeloid leukemia
por: Zhang, Xiang, et al.
Publicado: (2023)

Outcomes of allogeneic transplant in patients with DDX41 mutated myelodysplastic syndrome and acute myeloid leukemia
por: Baranwal, Anmol, et al.
Publicado: (2022)

Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia
por: Cheng, Zhiheng, et al.
Publicado: (2020)

Signaling mechanisms that regulate ex vivo survival of human acute myeloid leukemia initiating cells
por: Bhavanasi, Dheeraj, et al.
Publicado: (2017)

The immunometabolic landscape of the bone marrow microenvironment in acute myeloid leukemia
por: Xu, Binyan, et al.
Publicado: (2022)

High Expression Levels of ACTN1 and ACTN3 Indicate Unfavorable Prognosis in Acute Myeloid Leukemia
por: Yang, Xinrui, et al.
Publicado: (2019)

Efficacy and influencing factors of allogeneic hematopoietic stem cell transplantation in treatment of 71 children with leukemia
por: Zhang, Bing-Lei, et al.
Publicado: (2019)

High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia
por: Shi, Jinlong, et al.
Publicado: (2016)

Genomic landscape of hyperleukocytic acute myeloid leukemia
por: Largeaud, Laetitia, et al.
Publicado: (2022)

Integrative molecular subtypes of acute myeloid leukemia
por: Mo, Qianxing, et al.
Publicado: (2023)

Haploidentical vs matched sibling donor transplant for paroxysmal nocturnal haemoglobinuria: A multicenter study
por: Liu, Limin, et al.
Publicado: (2022)

ssExpression level of GAS6-mRNA influences the prognosis of acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation
por: Yang, Xinrui, et al.
Publicado: (2019)

Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia
por: Pautas, Cécile, et al.
Publicado: (2021)

Impact of Covid-19 on the treatment of acute myeloid leukemia
por: Ferrara, Felicetto, et al.
Publicado: (2020)

Orthodontic treatment for a patient with acute myeloid leukemia
por: Hsin-Chung Cheng, Johnson, et al.
Publicado: (2022)

Characterizing the Molecular Abnormalities in Rare De Novo Ph(+) Acute Myeloid Leukemia
por: Chao, Hong-Ying, et al.
Publicado: (2018)

JOSD2 regulates PKM2 nuclear translocation and reduces acute myeloid leukemia progression
por: Lei, Hu, et al.
Publicado: (2022)

Deoxyshikonin Inhibits Viability and Glycolysis by Suppressing the Akt/mTOR Pathway in Acute Myeloid Leukemia Cells
por: Wu, Huijuan, et al.
Publicado: (2020)

High expression of dedicator of cytokinesis 1 adversely influences the prognosis of acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
por: Zhang, Gaoqi, et al.
Publicado: (2019)

Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia
por: Pitel, Beth A., et al.
Publicado: (2023)

Complete response of myeloid/lymphoid neoplasms with PDGFRA rearrangement presenting as leukemia/myeloid sarcoma to imatinib monotherapy
por: Ma, Rui, et al.
Publicado: (2019)

Plasmacytoid Dendritic Cells Proliferation Coexisted with Acute Myeloid Leukemia
por: Wang, Min, et al.
Publicado: (2018)

Dissecting causes for improved survival among patients with acute myeloid leukemia in two different eras receiving identical regimens in sequential randomized studies
por: Tiong, Ing S., et al.
Publicado: (2018)

Rare variants in Fanconi anemia genes are enriched in acute myeloid leukemia
por: Maung, Kyaw Ze Ya, et al.
Publicado: (2018)

B Cell Deficiency in Patients with Relapsed and Refractory Acute Myeloid Leukemia
por: Goswami, Meghali, et al.
Publicado: (2020)

Asciminib in chronic myeloid leukemia: many questions still remain to be answered
por: Eşkazan, Ahmet Emre
Publicado: (2021)

Identification of a novel NPM1 mutation in acute myeloid leukemia
por: Yao, Yiyi, et al.
Publicado: (2023)

Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2022 ASH annual meeting
por: Gong, Xubo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r259hpnspvgp3uqk55e61ca3ut